Evoked potentials for evaluation of multiple sclerosis

Clinical Neurophysiology

Volumn 112, Issue 12, 2001, Pages 2185-2189

  Fuhr, P ^a   Kappos, L ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Course; Demyelination; Evoked potentials; MRI; Multiple sclerosis; Prediction

Indexed keywords

BRAIN ELECTROPHYSIOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE COURSE; EVOKED MUSCLE RESPONSE; EVOKED RESPONSE; EVOKED SOMATOSENSORY RESPONSE; EVOKED VISUAL RESPONSE; HUMAN; IMAGING; IMMUNOLOGY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; REVIEW;

EVOKED POTENTIALS; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; PROGNOSIS;

EID: 0035217177     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-2457(01)00687-3     Document Type: Review

References (74)

1. Serial evoked potential studies in patients with definite multiple sclerosis. Clinical relevance
2. Evoked potentials to test a treatment of chronic multiple sclerosis
3. A comparison of motor evoked potentials and somatosensory evoked potentials in patients with multiple sclerosis and potentially related conditions
4. Serial pattern shift visual evoked potentials in multiple sclerosis
5. Multimodal sensory and motor evoked potentials in a two-year follow-up study of MS patients with relapsing course
6. Diagnostic value of paraclinical tests in multiple sclerosis: Relative sensitivities and specifities for reclassification according to the Poser committee criteria
7. Central fatigue as revealed by postexercise decrement of motor evoked potentials
8. The pattern visual evoked potential. A multicenter study using standardized techniques
9. The triple stimulation technique to study central motor conduction to the lower limbs
10. Short-latency somatosensory evoked potentials: Interpretation
11. Corticospinal conduction studied with magnetic double stimulation in the intact human
12. European/Canadian Multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging measured disease activity and burden in patients with relapsing multiple sclerosis
13. Measuring evoked responses in multiple sclerosis
14. Tracking neuronal fiber pathway in the living human brain
15. Persistent functional deficit in multiple sclerosis and autosominal dominant cerebellar ataxia is associated with axon loss
16. MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis
17. Early structural changes in acute MS lesions assessed by serial magnetization transfer studies
18. Evoked potentials in clinical trials for multiple sclerosis
19. Motor evoked potentials and disability in secondary progressive multiple sclerosis
20. Linking structural, metabolic and functional changes in multiple sclerosis
21. Serial MRI, VEP, SEP and biotesiometry in acute optic neuritis: Value of baseline results to predict the development of new lesions at one year follow up
22. Visual and motor evoked potentials in the course of multiple sclerosis
23. The contribution of magnetic resonance imaging in the differential diagnosis of the damage to the cerebral hemispheres
24. Practice parameter: The usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology
25. Mitoxantrone in progressive multiple sclerosis: A placebo-controlled, randomized, observer-blind phase III trial: Clinical results and three-year follow-up
26. Changes in motor evoked potentials to short-interval paired transcranial magnetic stimuli in multiple sclerosis
27. The Effect of Intramuscular Interferon beta-1a treatment initiated at the time of a first acute clinical demyelinating event on the rate of development of clinically definite multiple sclerosis
28. Brain atrophy as a surrogate marker in MS. Faster, simpler, better?
29. The role of magnetic stimulation as a quantifier of motor disability in patients with multiple sclerosis
30. Magnetic stimulation as a quantifier of motor disability
31. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: A meta-analysis
32. Multimodality evoked potentials and blink reflex in multiple sclerosis
33. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
34. Serial evoked potentials in multiple sclerosis bouts. Relation to steroid treatment
35. Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-β1a in relapsing-remitting multiple sclerosis
36. Central fatigue assessed by transcranial magnetic stimulation
37. Clinical and magnetic resonance imaging predictors in primary and secondary progressive MS
38. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
39. A clinical study of motor evoked potentials using a triple stimulation technique
40. Magnetic resonance imaging techniques to monitor short term evolution of multiple sclerosis and to use in preliminary trials
41. Nuclear magnetic resonance monitoring of treatment and prediction of outcome in multiple sclerosis
42. The role of magnetic resonance techniques in understanding and managing multiple sclerosis
43. Effect of interferon β-1b on MRI outcomes in secondary progressive multiple sclerosis: Results of a European multicentre, randomised, double-blind, placebo-controlled trial
44. The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis
45. Frequency-dependent conduction delay of motor-evoked potentials in multiple sclerosis
46. Multiple sclerosis
47. Evoked potentials predict the clinical changes in a multiple sclerosis drug study
48. Evoked potential abnormality scores are a useful measure of disease burden in relapsing-remitting multiple sclerosis
49. Assessment of MRI criteria for diagnosis for multiple sclerosis
50. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up
51. Magnetic resonance techniques to monitor the long term evolution of multiple sclerosis pathology and to monitor definitive clinical trials
52. Motor-evoked potentials in response to fatiguing grip exercise in multiple sclerosis patients
53. New diagnostic criteria for multiple sclerosis: Giudelines for research protocols
54. Magnetic resonance imaging changes with recombinant human interferon-bata-1a: A short term study in relapsing-remitting multiple sclerosis
55. Demyelinating diseases
56. Sensory (VEP, BAEP, SEP) and motor-evoked potentials, liquoral and magnetic resonance findings in multiple sclerosis
57. Use of brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS
58. Improvement in motor evoked potentials and clinical course post-steroid therapy in multiple sclerosis
59. Walking and fatigue in multiple sclerosis: The role of the corticospinal system
60. Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis
61. Interferon beta-1b in the treatment of multiple sclerosis
62. Axonal transection in the lesions of multiple sclerosis
63. Accumulation of hypointense lesions ('black holes') on T1 spin-echo MRI correlates with disease progression in multiple sclerosis
64. Magnetic stimulation of corticospinal pathways at the foramen magnum level in humans
65. Suppression of motor cortical excitability by electrical stimulation over the cerebellum in ataxia
66. Correlation of volumetric magnetization transfer imaging with clinical data in multiple sclerosis
67. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability
68. Correlating MRI and clinical disease activity in multiple sclerosis: Relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images
69. Human motor evoked responses to paired transcranial magnetic stimuli
70. Clinical course and electrophysiology of multiple sclerosis
71. The natural history of multiple sclerosis: A geographically based study. I. Clinical course and disability
72. Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: A functional magnetic resonance imaging study
73. Functional magnetic resonance imaging in multiple sclerosis